2012
DOI: 10.1016/j.neurobiolaging.2011.09.021
|View full text |Cite
|
Sign up to set email alerts
|

Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
74
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 86 publications
(77 citation statements)
references
References 36 publications
3
74
0
Order By: Relevance
“…The association of SV2A with AD has not been described, but some disorientation in AD is associated with epileptiform activity and might be prevented with antiepileptic drugs (62). In contrast, VGLUT1, the vesicular glutamate transporter in neurons, has been found to be differentially expressed in different AD mouse models (63,64). The observation that FE65 is associated with synaptic plasticity (65) might in part be due to the interaction of FE65 with SV2A and VGLUT1.…”
Section: Discussionmentioning
confidence: 99%
“…The association of SV2A with AD has not been described, but some disorientation in AD is associated with epileptiform activity and might be prevented with antiepileptic drugs (62). In contrast, VGLUT1, the vesicular glutamate transporter in neurons, has been found to be differentially expressed in different AD mouse models (63,64). The observation that FE65 is associated with synaptic plasticity (65) might in part be due to the interaction of FE65 with SV2A and VGLUT1.…”
Section: Discussionmentioning
confidence: 99%
“…23,24) On the other hand, dysfunction in neurotransmission mediated by the inhibitory neurotransmitter GABA is related to the onset and development of several neurological disorders including epilepsy and insomnia. 25,26) The high-affinity transporters for glutamic acid and GABA are EAAT and GAT, respectively, but the low-affinity transporters are unclear.…”
Section: Physiological Roles Of Organic Cation Transporters In Neuronsmentioning
confidence: 99%
“…In brain neurons, on the other hand, the OCTN1-mediated uptake of ERGO could play a protective role against the oxidative stress related to the development of various neurological disorders, including Alzheimer's, Parkinson's, and Huntington's diseases. 23,46) In addition, OCTN1 is functionally expressed in neural stem cells as well as neurons, and the OCTN1-mediated uptake of ERGO promotes differentiation of neural stem cells into neurons. 35) Taken together, the induction of OCTN1 and/or the ingestion of ERGO are conceivable as treatments for neurological disorders associated with OCTN1.…”
Section: )mentioning
confidence: 99%
“…It is considered that neurodegeneration owing to oxidative stress is related to the development of various brain diseases, including Alzheimer's, Parkinson's and Huntington's diseases (Sayre et al, 2008;Cassano et al, 2012). OCTN1 may therefore influence the development of neurodegenerative diseases via its role in transporting endogenous antioxidants.…”
mentioning
confidence: 99%